These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Determination of malondialdehyde in human blood by headspace-solid phase micro-extraction gas chromatography-mass spectrometry after derivatization with 2,2,2-trifluoroethylhydrazine.
    Author: Shin HS.
    Journal: J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov 01; 877(29):3707-11. PubMed ID: 19800854.
    Abstract:
    Malondialdehyde (MDA) has been proposed as a useful biomarker of lipoperoxidation in biological samples, and more developed analytical methods are necessary. A simple and sensitive gas chromatography-mass spectrometry (HS-SPME-GC-MS) was described for the determination of malondialdehyde (MDA) in blood. Acetone-d(6) was used as internal standard. MDA and acetone d6 in blood reacted for 40 min at 50 degrees C with 2,2,2-trifluoroethylhydrazine in headspace vial and simultaneously the formed TFEH derivatives were vaporized and adsorbed on polydimethylsiloxane-divinylbenzene (PDMS-DVB). The compounds were desorbed for 1 min at 240 degrees C and injected in GC-MS. The reaction solution showed good recoveries at pH 4.0. In the established condition, the method detection limit (MDL) was 0.4 microg/L in 0.1 mL blood sample and the relative standard deviation was less than 8% at the concentration of 25.0 and 50.0 microg/L. The mean concentrations of MDA in normal human blood (n=20) were measured to be 187.9 microg/L (2.61 micromol/L).
    [Abstract] [Full Text] [Related] [New Search]